Gladstone in the News
December 13, 2020
Forbes—In an article about the need for rapid testing to monitor and curb the COVID-19 pandemic, Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains the advantages of the CRISPR- and smartphone-based detection platform she developed with Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Doudna Lab
Ott Lab
Gladstone in the News
December 11, 2020
San Francisco Business Times—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, discusses the rapid, smartphone-based Coronavirus detection assay her group recently described in the scientific publication Cell. The assay was developed by Graduate Student Parinaz Fozouni, in collaboration with the labs of Senior Scientist and Nobel Laureate Jennifer Doudna, PhD, and of UC Berkeley Bioengineering Professor Dan Fletcher, PhD.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Doudna Lab
Ott Lab
Gladstone in the News
November 17, 2020
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on recent findings by her group and others that COVID-19 patients retain immune cells against the new coronavirus for several months after infection, which bodes well for the ability of vaccines to provide lasting protection against the disease.
Gladstone Experts
COVID-19
Virology
Roan Lab